SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCONI, Peggy Carla Raffaella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.327
EU - Europa 1.927
AS - Asia 1.113
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
OC - Oceania 1
Totale 10.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.323
CN - Cina 645
UA - Ucraina 502
IT - Italia 348
GB - Regno Unito 305
PL - Polonia 296
TR - Turchia 289
DE - Germania 218
SG - Singapore 122
FI - Finlandia 105
SE - Svezia 67
BE - Belgio 27
ID - Indonesia 26
FR - Francia 24
VN - Vietnam 13
AT - Austria 10
IR - Iran 6
ES - Italia 5
BR - Brasile 4
NL - Olanda 4
CA - Canada 3
CZ - Repubblica Ceca 3
HK - Hong Kong 3
IE - Irlanda 3
IN - India 3
RU - Federazione Russa 3
CH - Svizzera 2
EU - Europa 2
IL - Israele 2
KR - Corea 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
IQ - Iraq 1
JP - Giappone 1
LI - Liechtenstein 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
PE - Perù 1
VE - Venezuela 1
Totale 10.380
Salva come PNG Salva come JPEG
Città #
Fairfield 1.037
Woodbridge 1.028
Houston 589
Jacksonville 557
Chandler 495
Ashburn 466
Ann Arbor 436
Seattle 402
Wilmington 352
Cambridge 335
Warsaw 296
New York 227
Izmir 186
Ferrara 153
Nanjing 146
Beijing 135
Princeton 134
San Diego 105
Singapore 69
Shanghai 57
Boardman 53
Shenyang 53
Milan 42
Hebei 37
Jiaxing 34
Tianjin 33
Nanchang 31
Brussels 27
Changsha 25
Jakarta 25
Falls Church 20
Los Angeles 19
Mountain View 18
Norwalk 18
Ningbo 15
San Mateo 15
Bologna 14
Jinan 14
Redwood City 14
Washington 14
Auburn Hills 13
Dong Ket 13
Orange 13
Kunming 12
Zhengzhou 11
Chicago 10
London 10
Vienna 10
Des Moines 9
Leawood 9
Modena 9
Taizhou 9
Ferrara di Monte Baldo 8
Verona 7
Augusta 6
Monmouth Junction 6
Guangzhou 5
Ardabil 4
Changchun 4
Hangzhou 4
Indiana 4
Lappeenranta 4
Philadelphia 4
Bari 3
Bremen 3
Brno 3
Dearborn 3
Dublin 3
Hounslow 3
Pieve Emanuele 3
Tappahannock 3
Toronto 3
Turin 3
Acton 2
Amsterdam 2
Anzola 2
Como 2
Custom House 2
Hong Kong 2
Kilburn 2
Lanzhou 2
Madrid 2
Munich 2
Napoli 2
Padova 2
Paris 2
Pegola 2
Pune 2
Redmond 2
Stienta 2
Stockholm 2
Taunton 2
Trumbull 2
Valeggio sul Mincio 2
Wandsworth 2
Addison 1
Alcalá De Henares 1
Andover 1
Aprilia 1
Baghdad 1
Totale 7.989
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 189
null 179
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 162
Recombinant herpes simplex virus and uses therefor 153
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 150
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 148
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 136
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 129
HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma 125
Herpes Simplex Virus Growth, Preparation, and Assay 125
CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis 125
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 121
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 120
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 119
Peripheral T Cells Re-Enter the Thymus and Interfere with Central Tolerance Induction 116
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 115
Parenchymal cells critically curtail cytotoxic T-cell responses by inducing Bim-mediated apoptosis 114
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 112
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 111
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 109
Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines 108
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 108
HSV as a vector in vaccine development and gene therapy 107
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity 107
MHC class I cross-presentation by dendritic cells counteracts viral immune evasion 107
Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8(+) T cell tolerance in vivo 106
Development and application of replication-incompetent HSV-1-based vectors 106
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 105
null 104
Herpetic vectors inhibiting angiogenesis and Inducing cell suicide in gliomas 104
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice 103
Gene transfer to muscle using herpes simplex virus-based vectors 103
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 103
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 102
Construction of Replication Defective Herpes Simplex Virus Vectors. 101
Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance. 100
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 100
Development of Replication-Defective Herpes Simplex Virus Vectors 100
Purinergic Signaling: A New Pharmacological Target Against Viruses? 100
Botulinum neurotoxin light chains expressed by defective herpes simplex virus type-1 vectors cleave snare proteins and inhibit cgrp release in rat sensory neurons 100
Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo 99
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications 99
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 98
HSV as a vector in vaccine development and gene therapy 97
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG35-55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice 96
Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model 96
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 96
Engineering herpes simplex virus vectors for CNS applications 95
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector 95
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons 95
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 94
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis 94
Implications of maturation for viral gene delivery to skeletal muscle 94
Herpes Simplex Virus Type 1-Derived Recombinant and Amplicon Vectors 93
Connexin 43-enhanced suicide gene therapy using herpesviral vectors 92
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 92
Gene transfer to muscle and spinal cord using herpes simplex virus-based vectors. 92
Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis 91
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 91
Replication-defective herpes simplex virus vectors for gene transfer in vivo 90
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 89
null 89
null 89
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 88
Rapid method for construction of recombinant HSV gene transfer vectors 87
Cytokine gene delivery into the central nervous system using intrathecally injected nonreplicative viral vectors 84
null 84
Virus erpetici come vettori vaccinali 83
Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy 82
Temporal lobe epilepsy model, neural stem cells and gene therapy 82
Capitolo 55 Retrovirus 81
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 81
null 81
Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment 81
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 81
Strain specific maturation of Dendritic cells and production of IL-1β controls CD40-driven colitis 77
Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system 74
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 74
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 70
Gene Therapy: a possible future option for multiple sclerosis 66
Herpes Simplex Virus Growth, Preparation, and Assay 65
Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes 64
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 64
Chapter 12:Unit 12.11. Construction of Replication-Defective Herpes Simplex Virus Vectors 63
Engineering herpes simplex virus vectors for human gene therapy. 62
Niosomes containing HSV immunogens as possible vaccine against genital herpes 62
Herpes Simplex Virus mediated gene transfer to neurons. 60
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 60
Herpes simplex virus vectors for gene transfer to the nervous system 60
Capitolo 44 Herpesviridae 59
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 58
Chapter 7 Gene Transfer to Muscle and Spinal Cord Using Herpes Simplex Virus-Based Vectors 57
The expression of immediate early genes of herpes simplex virus type 1 contributes to the neuroplasticity induced by viral infection on the enteric nervous system 57
In vivo transgene activation from an HSV-based gene therapy vector by GAL4:VP16 56
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 55
Molecular analysis of behavior by gene transfer into neurons with herpes simplex vectors 54
Herpes simplex gene therapy vectors for the treatment of cancer. 54
Virus vectors for immunoprophylaxis 53
Chapter 8: Gene-transfer Tool: Herpes Simplex Virus Vectors 53
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 53
Totale 9.413
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.923
Totale 50.406
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019558 0 0 0 0 0 0 0 0 0 0 0 558
2019/20202.464 405 88 113 380 172 254 199 253 189 205 139 67
2020/20211.673 139 168 93 161 104 174 83 191 46 235 180 99
2021/20221.364 46 182 72 63 50 45 93 77 61 101 134 440
2022/20231.192 146 29 63 135 158 180 46 138 172 21 72 32
2023/2024884 79 84 42 26 39 264 55 43 21 25 22 184
Totale 10.562